Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Skin Cancer
Recent news which mentions Skin Cancer
OncoBeta reports 12-Month Results from International Phase IV Study for Non-Melanoma Skin Cancer
August 13, 2025
Tags
Germany
Squamous Cell Carcinoma
EPIC/Skin
From
PRLog
Silent Skin Cancer Danger Lurking in Unexpected Places
May 12, 2025
Tags
Medical
Houston
Health
From
PRLog
OncoBeta introduces Rhenium-SCT for non-melanoma skin cancer patients at Hospital Universitario 12 de Octubre
June 20, 2024
Tags
Munich
Science
Rhenium
From
PRLog
New Study Suggests Cannabis Sativa Extracts Could Help Prevent Or Reverse Sun Damage
June 04, 2024
Tickers
NEWS
Tags
skin damage
Cannabis Research
Benzinga
From
Benzinga
Each Year, The Friday before Memorial Day is Declared ‘Don’t Fry Day’ to Encourage Sun Safety and Awareness
May 22, 2024
Tickers
AP
Tags
Dermatology and Skin Care
AP
Don't Fry Day
From
Send2Press Newswire
Focusing on Treatment Education this May for Skin Cancer Awareness Month in UK
May 17, 2024
Tags
Munich
marylebone
London, Greater
From
PRLog
'Spot Detective' – Check your spots this summer
November 22, 2022
Tags
Melbourne
Spot Detective
Skin Cancer
From
PRLog
Protecting You and Your Family from Skin Cancer This Summer
May 31, 2022
Tags
melanoma
skin cancer
Intermountain Healthcare
From
PRUnderground
OncoBeta initiates international EPIC-Skin study with Rhenium-SCT® for the treatment of Skin Cancer
September 09, 2021
Tags
Technology
Bavaria
Aesthetic
From
PRLog
MediWound Starts Testing MW005 In Two Mid-Stage Trials In Patients With Non-Melanoma Skin Cancer
July 26, 2021
Tickers
MDWD
Tags
Briefs
Penny Stocks
News
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.